NFKB1 and ovarian carcinoma: In addition, PF treatment exerts powerful anti-cancer effects via the upregulation of CDH2, the downregulation of CDH1, and the inhibition of the NF-kB signaling pathway in ovarian cancer cells and cisplatin-resistant ovarian cancer cells [26].